Global Pharmaceutical Excipients Market
Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. Pharmaceutical excipients are cost effective, stable, feasible for handling, and inert in the nature. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others.
Global pharmaceutical excipients market is driven by increase in demand for oral drugs. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.
The Pharmaceutical Excipient Market has been segmented by product, function, end-user, and geography.
On the basis of product, pharmaceutical excipient market is segmented as:
- Inorganic Chemicals
- Calcium Phosphates
- Calcium Carbonate
- Calcium Sulphate
- Metallic Oxides
- Organic Chemicals
- Glycols (alcohol)
- Povidones polymers
- Mineral Hydrocarbons
- Gelatin (Proteins)
On the basis of function, pharmaceutical excipient market is segmented as:
- Fillers and Diluents
- Flavouring Agents
On the basis of dosage form, pharmaceutical excipient market is segmented as:
On the basis of the end-user, pharmaceutical excipient market is segmented as:
- Biotech Companies
- Pharmaceutical Companies
- Research Institutes
Global pharmaceutical excipients market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipients market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period. Business expansions, new product launches, mergers & acquisitions and collaborations with educational universities are the key strategies adopted by most companies in the global pharmaceutical excipients market.
The global market of pharmaceutical excipients is segmented into 5 key regions, North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.. North America followed Europe dominates in terms of the size of the excipients market globally. Emerging market like Asia-Pacific is expected to show lucrative growth opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials. Countries such as Brazil, India, and China are expected to be the major contributors to the growth of pharmaceutical excipients market owing to rising per capita income and most of the companies present in developed regions willing to establish manufacturing facilities in developing regions due to their low cost of manufacturing and processing.
Some of the players operating in global pharmaceutical excipients market are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK),Merck KGaA (U.S.) and Lubrizol Corporation (U.S.) to name a few.
- In June 2017, Ashland Inc. got US patent for purekote 23589 (dispersion) and purekote 21412a (cross linking agent) coating system
- In April 2017, Lubrizol Corporation’s Skin Essentials division launched new acrylate-based polymeric emulsifier Pemulen EZ-4U
- In July 2016, The Lubrizol Corporation acquired Diamond Dispersions Ltd to expand its product portfolio that enable digital painting
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario